Сlinical features of hypertrophic cardiomyopathy depending on the age of onset of clinical manifestations and the presence of cardiometabolic risk factors

The objective was to study the clinical features of symptomatic hypertrophic cardiomyopathy (HCM) depending on the age of onset and the presence of cardiometabolic risk factors.Methods and materials. From 2014 to 2020, 250 patients were examined, 100 patients with symptomatic HCM aged 18 to 86 years...

Full description

Saved in:
Bibliographic Details
Main Authors: V. G. Davydova, Е. I. Baranova, T. G. Bezhanishvili, A. N. Krutikov, A. A. Poliakova, S. A. Pyko, A. Ya. Gudkova
Format: Article
Language:Russian
Published: Academician I.P. Pavlov First St. Petersburg State Medical University 2023-05-01
Series:Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:
Online Access:https://www.sci-notes.ru/jour/article/view/916
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective was to study the clinical features of symptomatic hypertrophic cardiomyopathy (HCM) depending on the age of onset and the presence of cardiometabolic risk factors.Methods and materials. From 2014 to 2020, 250 patients were examined, 100 patients with symptomatic HCM aged 18 to 86 years were included in the study.Results. The incidence of arterial hypertension (AH), obesity, and angina syndrome was significantly higher in patients with HCM aged 45 years and older. The patients with HCM and associated obesity had greater left ventricular end-diastolic dimension and left antero-posterior size regardless of the age of onset of clinical manifestations. The young patients with HCM and associated obesity had more often AH. Patients with HCM with the disease onset ≥ 45 years of age and associated obesity had greater left ventricular posterior wall thickness, left ventricular end-diastolic dimension index. In this group of patients, pulmonary hypertension was more often diagnosed.Conclusion. Obesity and other cardiometabolic risk factors are predictors of the progressive course of HCM, which points the need for their prevention and timely correction.
ISSN:1607-4181
2541-8807